Scientific Meeting

This year’s meeting will feature 18 scientific sessions covering all disease groups and major topics in pediatric neuro-oncology, moderated by world experts in these areas.  Sessions will include keynote and summary talks, as well as presentations of top-scoring original research abstracts. For the first time, ISPNO 2018 Denver will feature a dedicated neurofibromatosis session with presentations by prominent NF researchers.  In addition, there will be two special immunotherapy sessions: an Education Day session with presentations by experts in the field, as well as a session during the main meeting that will include top-scoring immunotherapy abstracts.

New!  Late Breaking Abstracts

  • Updates on the Phase II and Re-Treatment Study of AZD6244 for Children with Recurrent or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study will be presented Sunday, July 1 in the Low Grade Glioma Session 
  • Brain Radiation Dosimetry Correlates with Neurocognitive Outcomes in Pediatric Medulloblastoma will be presented Tuesday, July 3 in the Medulloblastoma Clinical Session
  • Intratumoral administration of an Oncolytic Polio/Rhinovirus Recombinant (PVSRIPO) in malignant glioma patients: assessment of safety, survival outcomes and mutational correlates (Duke University) will be presented Monday, July 2 in the Early Phase Trials Session

Poster sessions on July 1st and July 2nd will feature original research in all areas.

Sunday and Monday mornings will feature both special sunrise sessions and lunch break out sessions.

Scientific Program Chairs:

Sunrise Session Chairs:

Featured Session Speakers

Roger Packer
Keynote Presentation

Darren Hargrave
Low Grade Glioma

Suzanne Baker
High Grade Glioma

Amar Gajjar
Medulloblastoma, Clinical

Sunrise Sessions

Lunch Sessions